Business
Why did the Exopharm (ASX:EX1) share price surge 12% today?

The Exopharm Ltd (ASX: EX1) share price rocketed today after the company announced positive clinical trial results for its regenerative medical product, Plexaris.
At market close, the Exopharm share price is up by 12.93% today to 65 cents per share.
Exopharm is a biopharmaceutical company focused on developing regenerative medicine. It’s currently investigating the therapeutic potential of two products, Plexaris and Cevaris, in treating osteoarthritis.
The company was undergoing clinical trials to see if the medicine can restore arthritic cell tissue in rats. These clinical trials showed that the drugs had no adverse affects and were safe to trial on humans, however they also showed that drugs’ efficacy was limited to milder…
-
Business24 hours ago
The ultimate Australian stocks to buy and hold for 10+ years
-
Noosa News19 hours ago
LNP Premier David Crisafulli announces ‘Queensland’s royal commission’ into CFMEU
-
General15 hours ago
Algal bloom ‘disaster’ prompts royal commission call as impact spreads to mussel farms
-
Noosa News20 hours ago
Southern NSW farmers call for financial relief as ongoing drought takes a toll